AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35485357 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (5 x 1 min at 80-95% maximal heart rate, twice weekly for 12 weeks)
Number of subjects: 46
Study 35485357 — intervention group
Group type: COMPARATOR
Intervention: CON (no exercise, nutritional counseling for weight loss)
Number of subjects: 46
Study 34791778 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy-sounding music
Number of subjects: 75
Study 34791778 — intervention group
Group type: COMPARATOR
Intervention: Sad-sounding music
Number of subjects: 75
Study 34263654 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) for OCD
Number of subjects: 4
Study 34075813 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban dose adjustment based on age, weight, and serum creatinine in NVAF.
Number of subjects: 0
Study 34075813 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacokinetic studies of apixaban in patients >65 years, those with extreme body weights, and those with advanced renal impairment.
Number of subjects: 0
Study 34219572 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactions to Homosexuality Scale (RHS)
Number of subjects: 5573
Study 33248546 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 m‐2 stocking density (high stocking density, HSD)
Number of subjects: 1440
Study 33248546 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 m‐2 stocking density (HSD)
Number of subjects: 1440
Study 35279070 — intervention group
Group type: EXPERIMENTAL
Intervention: TraumaApp (digital data collection tool)
Number of subjects: 50
Study 35279070 — intervention group
Group type: EXPERIMENTAL
Intervention: System Usability Score for TraumaApp
Number of subjects: 50
Study 35279070 — intervention group
Group type: COMPARATOR
Intervention: Paper proforma (control)
Number of subjects: 50
Study 33059195 — intervention group
Group type: EXPERIMENTAL
Intervention: TMP-SMX prophylaxis
Number of subjects: 61
Study 33059195 — intervention group
Group type: COMPARATOR
Intervention: Second-line medications (inhaled pentamidine, dapsone, atovaquone)
Number of subjects: 61
Study 34980495 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 42
Study 34980495 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 42
Study 34980495 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT)
Number of subjects: 42
Study 34980495 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide or ADT
Number of subjects: 42
Study 36147791 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 58
Study 36147791 — intervention group
Group type: EXPERIMENTAL
Intervention: Microfragmented Adipose Tissue (MFAT)
Number of subjects: 58
Study 32155257 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-Egger
Number of subjects: 0
Study 32155257 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-DoC
Number of subjects: 0
Study 35320363 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 5518
Study 35320363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5518
Study 34345969 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre‐emptive antibiotic treatment with clarithromycin (200 mg twice per day) during panitumumab treatment.
Number of subjects: 156
Study 34345969 — intervention group
Group type: COMPARATOR
Intervention: Control group with skin care only.
Number of subjects: 156
Study 34345969 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre‐emptive group (clarithromycin).
Number of subjects: 156
Study 34345969 — intervention group
Group type: COMPARATOR
Intervention: Control group (skin care only).
Number of subjects: 156
Study 32147077 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin 1000 mg/day for 12 weeks
Number of subjects: 70
Study 32147077 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 70
Study 35366069 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive training with feedback (PTWF)
Number of subjects: 72
Study 35366069 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive training no feedback (PTNF)
Number of subjects: 72
Study 35366069 — intervention group
Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 72
Study 32167011 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-CS6 BSIgG
Number of subjects: 59
Study 32167011 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-B7A BSIgG
Number of subjects: 59
Study 32167011 — intervention group
Group type: COMPARATOR
Intervention: Placebo (non-hyperimmune BSIgG)
Number of subjects: 59
Study 33598681 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote work
Number of subjects: 112
Study 33598681 — intervention group
Group type: COMPARATOR
Intervention: Diet, physical activity, and workday sedentary behaviour
Number of subjects: 112
Study 35319604 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotary (Hyflex EDM®) technique
Number of subjects: 40
Study 35319604 — intervention group
Group type: COMPARATOR
Intervention: Manual (k-file) technique
Number of subjects: 40
Study 35319604 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 40
Study 35319604 — intervention group
Group type: EXPERIMENTAL
Intervention: Restoration retention
Number of subjects: 40
Study 32208040 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic treatment for esophageal GISTs
Number of subjects: 16
Study 32208040 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative endoscopic biopsy
Number of subjects: 16
Study 33803720 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Step Marching Exercise (PSME) program for 8 weeks
Number of subjects: 60
Study 33803720 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal activity)
Number of subjects: 60
Study 32323437 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0
Study 32323437 — intervention group
Group type: COMPARATOR
Intervention: GLP-1 RA
Number of subjects: 0
Study 34645649 — intervention group
Group type: EXPERIMENTAL
Intervention: letrozole for 14 weeks
Number of subjects: 307
Study 34645649 — intervention group
Group type: EXPERIMENTAL
Intervention: letrozole for 2 weeks, then letrozole+palbociclib for 14 weeks
Number of subjects: 307
Study 34645649 — intervention group
Group type: EXPERIMENTAL
Intervention: palbociclib for 2 weeks, then letrozole+palbociclib for 14 weeks
Number of subjects: 307
Study 34645649 — intervention group
Group type: EXPERIMENTAL
Intervention: letrozole+palbociclib for 14 weeks
Number of subjects: 307
Study 34645649 — intervention group
Group type: COMPARATOR
Intervention: palbociclib
Number of subjects: 307
Study 33559351 — intervention group
Group type: EXPERIMENTAL
Intervention: Stryphnodendron adstringens (SA) at 3000 mg/L
Number of subjects: 8
Study 33559351 — intervention group
Group type: EXPERIMENTAL
Intervention: Lafoensia pacari (LP) at 300 mg/L
Number of subjects: 8
Study 33559351 — intervention group
Group type: EXPERIMENTAL
Intervention: Copaifera spp. (CO) at 300 mg/L
Number of subjects: 8
Study 33559351 — intervention group
Group type: EXPERIMENTAL
Intervention: Pterodon emarginatus (PE) at 30 and 300 mg/L
Number of subjects: 8
Study 33559351 — intervention group
Group type: EXPERIMENTAL
Intervention: Stryphnodendron adstringens (SA) at 300 mg/L
Number of subjects: 8
Study 33559351 — intervention group
Group type: EXPERIMENTAL
Intervention: Lafoensia pacari (LP) at 30 mg/L
Number of subjects: 8
Study 33169920 — intervention group
Group type: EXPERIMENTAL
Intervention: ThymLec 2%
Number of subjects: 0
Study 33169920 — intervention group
Group type: EXPERIMENTAL
Intervention: ThymLec 2% (in vitro)
Number of subjects: 0
Study 32056917 — intervention group
Group type: EXPERIMENTAL
Intervention: Comorbid PTSD
Number of subjects: 482
Study 35149571 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent, multidisciplinary implementation intervention
Number of subjects: 0
Study 35149571 — intervention group
Group type: COMPARATOR
Intervention: Control (preintervention period)
Number of subjects: 0
Study 34977544 — intervention group
Group type: EXPERIMENTAL
Intervention: TIMP (45 minutes)
Number of subjects: 30
Study 34977544 — intervention group
Group type: EXPERIMENTAL
Intervention: TIMP+cMI (30 minutes TIMP, 15 minutes metronome-cued motor imagery)
Number of subjects: 30
Study 34977544 — intervention group
Group type: EXPERIMENTAL
Intervention: TIMP+MI (30 minutes TIMP, 15 minutes motor imagery without cues)
Number of subjects: 30
Study 35452918 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated access to physiotherapy
Number of subjects: 33
Study 35452918 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised approach with a physiotherapist
Number of subjects: 33
Study 33307626 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective retina therapy (SRT)
Number of subjects: 68
Study 33307626 — intervention group
Group type: COMPARATOR
Intervention: Control (sham treatment)
Number of subjects: 68
Study 33722790 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined phacoemulsification plus ECP
Number of subjects: 48
Study 33722790 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification alone
Number of subjects: 48
Study 32654089 — intervention group
Group type: EXPERIMENTAL
Intervention: Hazard ratio
Number of subjects: 0
Study 32654089 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal hazard ratio
Number of subjects: 0
Study 32654089 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal hazard difference
Number of subjects: 0
Study 32105007 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers' behavior concerning the prevention of poisoning in children under the age of five years
Number of subjects: 580
Study 32105007 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers' related knowledge and HBM constructs
Number of subjects: 580
Study 35948694 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate discrimination training for 100- and 300-Hz pulse trains
Number of subjects: 77
Study 35948694 — intervention group
Group type: COMPARATOR
Intervention: Tone detection in noise (active control)
Number of subjects: 77
Study 35948694 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate discrimination training
Number of subjects: 77
Study 33430695 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) SUR1 expression in TBI patients
Number of subjects: 23
Study 33430695 — intervention group
Group type: COMPARATOR
Intervention: Cerebrospinal fluid (CSF) SUR1 expression in controls
Number of subjects: 23
Study 32103542 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based intervention (PTSD Clinicians Exchange) with ongoing access to resources and biweekly email reminders.
Number of subjects: 605
Study 32103542 — intervention group
Group type: COMPARATOR
Intervention: Newsletter-only control condition.
Number of subjects: 605
Study 35654589 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest plasma sDPP4 quartile
Number of subjects: 3564
Study 34377137 — intervention group
Group type: EXPERIMENTAL
Intervention: Zataria multiflora (ZM) extract syrup
Number of subjects: 30
Study 34377137 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 35931415 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV biofeedback before sleep
Number of subjects: 8
Study 33420265 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk model based on eight factors (age, ingestion volume, CK-MB, PLT, WBC, N, GGT, Cr)
Number of subjects: 1199
Study 33587552 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear model using the 20mSRT (laps), body mass index, and body fat percentage.
Number of subjects: 148
Study 33587552 — intervention group
Group type: EXPERIMENTAL
Intervention: Allometric model using the 20mSRT (laps), height, and body mass.
Number of subjects: 148
Study 32643674 — intervention group
Group type: EXPERIMENTAL
Intervention: SGB with 10 mL of 0.5% bupivacaine (Group B)
Number of subjects: 60
Study 32643674 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group S)
Number of subjects: 60
Study 36342703 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily low-dose aspirin (100 mg)
Number of subjects: 16703
Study 36342703 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16703
Study 33035140 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous androgen deprivation therapy (agonist or antagonist)
Number of subjects: 838
Study 32436638 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 14443
Study 32436638 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 14443
Study 35113042 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 1259
Study 35113042 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 1259
Study 32725500 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 U of abobotulinumtoxinA (ABO) per side for mild GS
Number of subjects: 41
Study 32725500 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 U of abobotulinumtoxinA (ABO) per side for moderate GS
Number of subjects: 41
Study 32725500 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 U, 5 U, or 7.5 U of abobotulinumtoxinA (ABO) per side for severe GS
Number of subjects: 41
Study 35921117 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant Chemoradiotherapy Plus Surgery
Number of subjects: 0
Study 35921117 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34028794 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy or laparotomy
Number of subjects: 471
Study 34028794 — intervention group
Group type: EXPERIMENTAL
Intervention: Gynaecology unit
Number of subjects: 471
Study 34028794 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic pain intensity
Number of subjects: 471
Study 34028794 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower parity
Number of subjects: 471
Study 34028794 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 471
Study 32555986 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental exhaustive cycling
Number of subjects: 17
Study 32555986 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental exhaustive running
Number of subjects: 17
Study 35619617 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Cranial-Auricular Acupoint Stimulation (TECAS)
Number of subjects: 470
Study 35619617 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 470
Study 32408361 — intervention group
Group type: EXPERIMENTAL
Intervention: 22G Acquire needle
Number of subjects: 60
Study 32408361 — intervention group
Group type: COMPARATOR
Intervention: 20G Procore needle
Number of subjects: 60
Study 35479268 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 180
Study 35479268 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 180
Study 35479268 — intervention group
Group type: COMPARATOR
Intervention: Control group (Guideline-Based Physical Activity)
Number of subjects: 180
Study 33818314 — intervention group
Group type: COMPARATOR
Intervention: Exercise group (E)
Number of subjects: 75
Study 33818314 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy group (LLLT)
Number of subjects: 75
Study 33818314 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual pressure release group (MPR)
Number of subjects: 75
Study 35446848 — intervention group
Group type: EXPERIMENTAL
Intervention: SUVfdg
Number of subjects: 481
Study 35837981 — intervention group
Group type: EXPERIMENTAL
Intervention: TOTUM-63 (5 g/day)
Number of subjects: 51
Study 35837981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 34757564 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention over 24 months
Number of subjects: 98
Study 34757564 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 98
Study 35147118 — intervention group
Group type: EXPERIMENTAL
Intervention: Shengyu Decoction
Number of subjects: 0
Study 33735707 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) treatment for 16 weeks
Number of subjects: 49
Study 33735707 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 16 weeks
Number of subjects: 49
Study 32997869 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (G1)
Number of subjects: 28
Study 32997869 — intervention group
Group type: COMPARATOR
Intervention: Control (TENS, G2)
Number of subjects: 28
Study 32997869 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture (G1) and Control (TENS, G2)
Number of subjects: 28
Study 35366858 — intervention group
Group type: EXPERIMENTAL
Intervention: Seminar-case learning (SCL) method
Number of subjects: 0
Study 35366858 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture-based learning (LBL) model
Number of subjects: 0
Study 33094470 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspergillus section Nigri strains identified through multiplex PCR
Number of subjects: 96
Study 33094470 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial sequencing of the CaM gene
Number of subjects: 96
Study 33094470 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of fum8 gene in A. welwitschiae isolates
Number of subjects: 96
Study 33094470 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of radH and pks genes in A. welwitschiae isolates
Number of subjects: 96
Study 33094470 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of fum8 gene presence with fumonisin production
Number of subjects: 96
Study 34903983 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline solution (HSS) 150 mL
Number of subjects: 28
Study 34903983 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 150 mL
Number of subjects: 28
Study 34903983 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups received 250 mg IV furosemide every 12 h for 48 h
Number of subjects: 28
Study 32487038 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiation (SABR) + radium-223 dichloride (6 infusions at 4-week intervals)
Number of subjects: 0
Study 32487038 — intervention group
Group type: COMPARATOR
Intervention: Stereotactic ablative radiation (SABR) alone
Number of subjects: 0
Study 32487038 — intervention group
Group type: EXPERIMENTAL
Intervention: SABR + radium-223 dichloride
Number of subjects: 0
Study 32487038 — intervention group
Group type: COMPARATOR
Intervention: SABR alone
Number of subjects: 0
Study 32997242 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper (Cu) at 1.25 ppm for 96 h and then 20, 30, and 40% for 30 days
Number of subjects: 4
Study 32997242 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadmium (Cd) at 4.5 ppm for 96 h and then 20, 30, and 40% for 30 days
Number of subjects: 4
Study 32997242 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of Cu and Cd at 2.25 ppm for 96 h and then 20, 30, and 40% for 30 days
Number of subjects: 4
Study 32997242 — intervention group
Group type: COMPARATOR
Intervention: Control group (not exposed to Cu or Cd)
Number of subjects: 4
Study 33009448 — intervention group
Group type: EXPERIMENTAL
Intervention: Crawl couch (CrC)
Number of subjects: 10
Study 33009448 — intervention group
Group type: COMPARATOR
Intervention: Standard prone breastboard (BB)
Number of subjects: 10
Study 33009448 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation group (40 left and right‐sided breast cancer patients)
Number of subjects: 10
Study 34240173 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae block
Number of subjects: 50
Study 34240173 — intervention group
Group type: COMPARATOR
Intervention: Serratus plane block
Number of subjects: 50
Study 34556166 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose intravenous iron (two different formulations) administered early in the second trimester
Number of subjects: 0
Study 34556166 — intervention group
Group type: COMPARATOR
Intervention: Standard doses of oral iron
Number of subjects: 0
Study 34556166 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose intravenous iron (two different formulations)
Number of subjects: 0
Study 32189424 — intervention group
Group type: EXPERIMENTAL
Intervention: ICG fluorescence angiography (ICG FA)
Number of subjects: 377
Study 32189424 — intervention group
Group type: COMPARATOR
Intervention: Non-ICG fluorescence angiography (visual clinical assessment)
Number of subjects: 377
Study 33491093 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed dye laser‐mediated photodynamic therapy
Number of subjects: 60
Study 33491093 — intervention group
Group type: COMPARATOR
Intervention: Conventional red‐light photodynamic therapy
Number of subjects: 60
Study 34246603 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 4796
Study 34246603 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 4796
Study 33253622 — intervention group
Group type: EXPERIMENTAL
Intervention: Linguistic-phonological intervention
Number of subjects: 14
Study 33253622 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor-phonetic intervention
Number of subjects: 14
Study 36380126 — intervention group
Group type: EXPERIMENTAL
Intervention: Early withdrawal of life-sustaining treatments based on presumed poor neurologic prognosis (WLST-N)
Number of subjects: 1040
Study 36380126 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with early WLST-N
Number of subjects: 1040
Study 36380126 — intervention group
Group type: EXPERIMENTAL
Intervention: Institutional variation in early WLST-N
Number of subjects: 1040
Study 36380126 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of multimodal prognostication
Number of subjects: 1040
Study 36380126 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of sedative medications in patients with early WLST-N
Number of subjects: 1040
Study 32665691 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic information and correlated trait
Number of subjects: 0
Study 32665691 — intervention group
Group type: COMPARATOR
Intervention: Group records with size 24
Number of subjects: 0
Study 32665691 — intervention group
Group type: COMPARATOR
Intervention: Random assignment of animals to pens
Number of subjects: 0
Study 32665691 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivariate model including correlated traits recorded individually
Number of subjects: 0
Study 32641081 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative immunonutrition (400 mL/day with arginine and ω‐3 fatty acids for 7 days)
Number of subjects: 176